NCT06407648

Brief Summary

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Apr 2024Dec 2026

Study Start

First participant enrolled

April 3, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

2.3 years

First QC Date

May 6, 2024

Last Update Submit

May 7, 2026

Conditions

Keywords

childrenadolescentsexposure with response preventioncognitive behavioral therapyERPCBT

Outcome Measures

Primary Outcomes (1)

  • Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) Total Severity Score

    A clinician-rated measure of OCD symptom severity in the past week. This 10-item measure is rated on a 0 to 5 scale with a total score ranging from 0 to 50. A higher total score is reflective of greater OCD symptom severity.

    Screen, Baseline (Week 0), Week 4, Week 8, and Week 12

Study Arms (2)

Personalized Assessments

EXPERIMENTAL

12 sessions of exposure with response prevention (ERP) that is guided by personalized assessments.

Other: Personalized Assessments

Standard of Care

ACTIVE COMPARATOR

12 sessions of exposure with response prevention (ERP) that is guided using standard practice.

Other: Standard of Care

Interventions

Personalized CBT will use individualized OCD symptom networks to guide CBT strategies to target central symptom nodes in contemporaneous networks.

Personalized Assessments

The standard CBT condition will use standard-of-care approaches to guide CBT strategies to target OCD symptoms.

Standard of Care

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • be 8-17 years of age;
  • meet diagnostic criteria for a primary diagnosis of OCD on a structured clinical interview;
  • have moderate OCD severity as evidenced by a CY-BOCS total score of ≥16;
  • medication free and/or on a stable dose of medication 8 weeks prior to study participation;
  • be English speaking.

You may not qualify if:

  • the presence of psychotic disorder, bipolar disorder, or autism spectrum disorders;
  • significant suicidal ideation that warrants medical intervention;
  • concurrent psychotherapy for OCD;
  • inability to complete scales, or attend visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, 21287, United States

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Joseph F. McGuire, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alexandra Chang

CONTACT

Lauren Browning

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized parallel clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 9, 2024

Study Start

April 3, 2024

Primary Completion (Estimated)

July 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations